Skip to main content
Journal of Genetic Engineering and Biotechnology

Table 3 Effect of intratumoral injection with 109 cells/ml of S. cerevisiae and S. cerevisiae-GNSs on FasL concentration in the negative, positive, and treatment groups

From: Gold nanoparticles combined baker’s yeast as a successful approach for breast cancer treatment

Parameter

FasL (ng/ml)

Groups

Mean ± S.E

Significance to normal

Significance to tumor

Significance to yeast group

Negative control (normal)

19.33 ± 1.45

–––––-

##

 + 

Positive control (tumor)

6.40 ± 0.83

**

–––––-

 +  + 

S. cerevisiae 109 (yeast group)

24.00 ± 2.08

*

##

–––––-

S. cerevisiae–GNSs

29.00 ± 2.08

*

##

 + 

  1. Significance relative to normal: *P ≤ 0.05 and **P ≤ 0.01; significance relative to tumor: ##P ≤ 0.01; significance relative to yeast: + P ≤ 0.05 and +  + P ≤ 0.01
Back to article page